Bill Maris
Bill Maris
Bill Maris is a venture capitalist and the CEO at GV, a venture capital firm established by Maris and funded through Alphabet. With approximately $2.4 billion under management and investments in Uber and Nest, the six-year-old fund is described as one of the hottest in Silicon Valley. Maris oversees all of GV’s funding activity and has a particular interest in next generation life sciences and artificial intelligence. He was instrumental in the formation of Google’s Calico project...
NationalityAmerican
ProfessionBusinessman
CountryUnited States of America
We are looking for highly technical, enthusiastic and capable entrepreneurs who have a healthy disregard for the impossible, and that's not always easy to find.
Humans are terrible at predicting the future. We really overestimate what we can do in the short term and underestimate what we can do in the long term... If we can glimpse even a couple of years into the future, even that's difficult to do.
We can get much better outcomes from people if we understand the genetic basis of the exact cancer that they have, what interventions might be most effective against it, what's worked in the past and what hasn't.
I would draw a really big distinction between competition, or potential competition, and a conflict of interest. A conflict of interest implies wrongdoing, whereas competition is really healthy.
I used to be a health-care investor a long time ago in the public markets. One thing I learned that we tried to apply here is that investing in small molecules, trying to invest in the next treatment, there's an element of gambling to that.
Say you have cancer - you have this broad thing we call cancer; we're going to irradiate you and pump this poisonous material into you and hope more of the bad stuff dies than the good. That is going to seem so medieval when we can fix it on a genetic level, and Foundation Medicine is the first step to diagnosing it on a genetic level.
People talk about the redistribution of wealth a lot, which is a very valid topic. But what about the redistribution of health? That's even more concentrated at the top.
Back in the late 1990s, venture capitalists got very excited about the Internet. A whole lot of money was poured into some companies that failed rather spectacularly, and a lot of people lost a lot of money.
As life expectancy extends beyond 80 years in some parts of the world, more people are struggling with brain diseases. For older people, Alzheimer's, Parkinson's, and other conditions become a major impediment to quality of life.
As computer intelligence gets better, what will be possible when we interface our brains with computers? It might sound scary, but early evidence suggests otherwise: interfacing brains with machines can be helpful in treating traumatic brain injury, repairing spinal cord damage, and countless other applications.
There are environmental threats to health; there are internal threats to health - genetic conditions, viral threats, diseases like cancer and Parkinson's. And then there are societal and global ones, like poverty and lack of nutrition. And unknown viral threats - everything from a new kind of influenza to hemorrhagic fever.
The reality is the technology exists now to extend life and have people live healthier, happier lives. Not to be kind of immortal - that's not what I'm talking about.
There are a lot of billionaires in Silicon Valley, but in the end, we are all heading to the same place. If given the choice between making a lot of money or finding a way to make people live longer, what do you choose?
Venture funds get beaten up for not investing in important things. Okay, if you want venture funds to invest in important things, then don't penalize or make fun of them when those important things don't work.